Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå : Áö¿ª ºÐ¼® - À¯Çü, ¹æ¹ý, »ùÇà À¯Çü, À¯·¡, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(-2030³â)
South & Central America DNA Extraction, Isolation, and Purification Market Forecast to 2030 - Regional Analysis - by Type, Method, Sample Type, Source, Application, and End User
Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº 2022³â¿¡ 1¾ï 116¸¸ ´Þ·¯°¡ µÇ¸ç, 2030³â¿¡´Â 1¾ï 9,364¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ÅÁ¦Ç°ÀÇ »ó½Ã¿Í ½ÂÀÎÀÌ Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀ» µÞ¹Þħ
»ý¸í °øÇÐ »ê¾÷Àº ±â¼úÀûÀ¸·Î ÷´Ü Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Å©°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú ½ÅÁ¦Ç°ÀÇ °³¹ß, »ó½Ã, ½ÂÀÎÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ½ÃÀå °ü°èÀÚµéÀº È¿À²ÀûÀÎ Á¦Ç° Çõ½Å°ú ½ÃÀå °³Ã´À» º¸ÀåÇϱâ À§ÇØ R&D Ȱµ¿À» ÃßÁøÇϰí ÀÖ½À´Ï´Ù. DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå¿¡ ÀÖ¾î¼ÀÇ ÃÖ±ÙÀÇ Á¦Ç° ¹ßÇ¥¿Í ½ÅÈï±¹ ½ÃÀåÀÇ °³Ã´À» ÀÌÇÏ¿¡ ¸î°³ ¼Ò°³ÇÕ´Ï´Ù.
CD Bioparticles»ç´Â ü¿Ü Áø´Ü, »ýÈÇÐ, ¼¼Æ÷ ºÐ¼®, ¼¼Æ÷ ºÐ¸®, ¸é¿ª ÃøÁ¤ µîÀÇ ÀÀ¿ë ºÐ¾ß¿¡¼ ´Ù¾çÇÑ Á¦Ç°À» Á¦Á¶,°ø±ÞÇÏ´Â ´ë±â¾÷ÀÔ´Ï´Ù. 2023³â 8¿ù, ȸ»ç´Â ¹«¼¼Æ÷ DNA(cfDNA), °Ô³ð DNA, Çö󽺹̵å DNA, Á¶Á÷ DNA, ¹ÌÅäÄܵ帮¾Æ DNA, PCRÀ» Æ÷ÇÔÇÑ DNAÀÇ ½Å¼ÓÇϰí Á¤È®ÇÑ ºÐ¸®¸¦ À§ÇØ ¸¸µé¾îÁø DNA ÃßÃâ ¹× Á¤Á¦ ŰƮÀÇ »õ·Î¿î ½Ã¸®ÁîÀÇ ¹ß¸Å¸¦ ¹ßÇ¥Çß½À´Ï´Ù. 2023³â 3¿ù BioEcho Life Sciences´Â Æ÷¸£¸»¸° °íÁ¤ ÆÄ¶óÇÉ Æ÷¸Å(FFPE) »ùÇÿ¡¼ DNA¸¦ ÃßÃâÇÏ´Â Çõ½ÅÀûÀÎ ¹æ¹ýÀ» Á¦°øÇÏ´Â EchoLUTION FFPE DNA KitÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. 2022³â 4¿ù Â÷¼¼´ë ±â¼úÀÇ ¼±µÎ ¾÷ü Áß ÇϳªÀÎ Ç»¸®°Õ ¹ÙÀÌ¿À½Ã½ºÅÛÁî´Â Ionic Cells to Pure DNA KitÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Å°Æ®´Â À̿ Á¤Á¦ ½Ã½ºÅÛÀÇ »ç¿ëÀÚ°¡ ¹éÇ÷±¸(WBC), ¸»ÃÊ Ç÷¾× ´ÜÇÙ±¸(PBMC), ¹è¾ç ¼¼Æ÷ ¹× ¼±º° ¼¼Æ÷¿¡¼ ´õ ³ôÀº ǰÁúÀÇ DNA¸¦ ÃßÃâ ÇÒ ¼ö ÀÖµµ·Ï ÃÖÀûȵǾî ÀÖ½À´Ï´Ù.
ÀÌ¿Í °°ÀÌ Á¦Ç° °³Ã´°ú ½ÅÈï±¹ ½ÃÀå Áõ°¡´Â DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀÇ ÇâÈÄ ¸î ³â°£ÀÇ ¼ºÀå¿¡ ÃæºÐÇÑ ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå °³¿ä
À¯Àü¼º ÁúȯÀÌ Áõ°¡ÇÔ¿¡ µû¶ó DNA ŰƮ, ½Ã¾à, Àåºñ µîÀÇ ½Å¼Ó Áø´Ü ¿É¼ÇÀÇ Ã¤¿ëÀÌ ÀÓ»óÀûÀ¸·Î ½Ã±ÞÇØÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Å¼ÓÇÑ ºÐ¼®°ú °íÁ¤¹Ð °Ë»ç °á°ú¸¦ ¾òÀ» ¼ö ÀÖ´Â DNA Á¦Ç°ÀÇ ÀåÁ¡°ú Æø³ÐÀº ¿ëµµ·ÎÀÇ »ç¿ëÀÌ Áß³²¹Ì¿¡¼ DNA ºÐ¼®ÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¾Æ¸£ÇîÆ¼³ª¿¡¼´Â À¯ÀüÇÐ, Á¾¾çÇÐ, ¼¼Æ÷ À¯ÀüÇп¡¼ ÷´Ü Áø´Ü Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó DNA Á¦Ç°ÀÇ Ã¤ÅÃÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. WHO¿¡ µû¸£¸é ¾Æ¸£ÇîÆ¼³ª¿¡¼´Â 2020³â¿¡ 130,878¸íÀÇ ½Å±Ô¾Ï ȯÀÚ°¡ ¹ß»ýÇÕ´Ï´Ù. ÀÌ À¯ÀüÀÚ ¹°ÁúÀº À¯ÀüÀÚ ÀÌ»óÀÇ Á¶±â ¹ß°ß°ú ¸ÂÃãÇü Ä¡·á Àü·«ÀÇ ÀԾȿ¡ µµ¿òÀÌ µÇ±â ¶§¹®ÀÔ´Ï´Ù. ÀÌó·³ ³ë³â Àα¸ Áõ°¡¿Í ¾ÏÀÇ ±ÞÁõÀº Á¤È®ÇÑ À¯ÀüÀÚ ºÐ¼®ÀÇ Á߿伺À» ºÎ°¢½Ã۰í Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀÇ ¼öÀͰú ¿¹Ãø(-2030³â)(±Ý¾×)
Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¼¼ºÐÈ
Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº À¯Çü, ¹æ¹ý, »ùÇà À¯Çü, À¯·¡, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡¿¡ µû¶ó ±¸ºÐµË´Ï´Ù.
À¯Çüº°·Î´Â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº ŰƮ, ±â±â, ½Ã¾àÀ¸·Î ºÐ·ùµË´Ï´Ù. 2022³â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå Á¡À¯À²Àº ŰƮ ºÐ¾ß°¡ ÃÖ´ë¿´½À´Ï´Ù.
±â¹ýº°·Î´Â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº ÈÇÐÀû ±â¹ý°ú ¹°¸®Àû ±â¹ýÀ¸·Î À̺е˴ϴÙ. 2022³â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå Á¡À¯À²Àº ÈÇÐÀû ¹æ¹ýÀÌ ´õ Å®´Ï´Ù. ÈÇÐÀû ¹æ¹ýÀº Æä³î Ŭ·Î·ÎÆ÷¸§, ½Ç¸®Ä«°Ö, ÇÁ·ÎÅ×À̳ªÁ¦ µîÀ¸·Î ¼¼ºÐȵ˴ϴÙ. ¹°¸®Àû ¹æ¹ýÀº ¶ÇÇÑ Àڱ⠺ñµå¿Í Á¾ÀÌ·Î ¼¼ºÐȵ˴ϴÙ.
»ùÇÃÀ¯Çüº°·Î º¸¸é, Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº Ç÷¾×, ü¾×, ±âŸ·Î ±¸ºÐµË´Ï´Ù. 2022³â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå Á¡À¯À²Àº Ç÷¾× ºÎ¹®ÀÌ ÃÖ´ë¿´½À´Ï´Ù.
À¯·¡º°·Î´Â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº °Ô³ð°ú ¹Ì»ý¹°·Î ±¸ºÐµË´Ï´Ù. 2022³â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå Á¡À¯À²Àº °Ô³ð ºÎ¹®ÀÌ Å®´Ï´Ù. ¹Ì»ý¹° ºÎ¹®Àº ¹ÚÅ׸®¾Æ¿Í ¹ÙÀÌ·¯½º·Î ¼¼ºÐȵ˴ϴÙ.
¿ëµµº°·Î Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº PCR °Ë»ç, Â÷¼¼´ë ½ÃÄö½Ì, ¸¶ÀÌÅ©·Î¾î·¹ÀÌ µîÀ¸·Î ºÐ·ùµË´Ï´Ù. Â÷¼¼´ë ½ÃÄö½Ì ºÎ¹®Àº 2022³â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸® ¹× Á¤Á¦ ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. PCR °Ë»ç ºÎ¹®Àº qPCR, ¸ÖƼÇ÷º½º PCR, 16S PCR µîÀ¸·Î ¼¼ºÐȵ˴ϴÙ.
ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº Áø´Ü¼¾ÅÍ,¿¬±¸¼Ò, Á¦¾à,¹ÙÀÌ¿À Á¦¾àȸ»ç, CRO, ±âŸ·Î ±¸ºÐµË´Ï´Ù. Áø´Ü¼¾ÅÍ ¹× ¿¬±¸¼Ò ºÎ¹®Àº 2022³â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸® ¹× Á¤Á¦ ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
±¹°¡º°·Î´Â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ Áß³²¹Ì·Î ºÐ·ùµË´Ï´Ù. ºê¶óÁúÀº 2022³â Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.
Bio-Rad Laboratories Inc, Danaher Corp, GE HealthCare Technologies Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Merck KGaA, Illumina Inc, Takara Bio Inc, Thermo Fisher Scientific Inc. ½ÃÀå¿¡¼ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ´ë±â¾÷ÀÔ´Ï´Ù.
¸ñÂ÷
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ÁÖ¿ä ÀλçÀÌÆ®
- Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå, ½ÃÀå ¸Å·Âµµ
Á¦3Àå Á¶»ç ¹æ¹ý
- Á¶»ç ¹üÀ§
- 2Â÷ Á¶»ç
- 1Â÷ Á¶»ç
Á¦4Àå Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå : ÁÖ¿ä »ê¾÷ ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ÃßÃâ,Á¤Á¦ DNAÀÇ »õ·Î¿î ¿ëµµ
- À¯ÀüüÇп¡¼ÀÇ ¿¬±¸°³¹ß Áõ°¡
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- °øÁ¤ÀÇ °íºñ¿ë°ú ¼÷·Ã ³ëµ¿ÀÚÀÇ Çʿ伺
- ½ÃÀå ±âȸ
- ÇâÈÄÀÇ µ¿Çâ
- ±â±â¿Í °ü·ÃµÈ ±â¼úÀÇ Áøº¸
- ¿µÇ⠺м®
Á¦5Àå DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå : Áß³²¹Ì ½ÃÀå ºÐ¼®
- Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¼öÀÍ(2022³â-2030³â)
Á¦6Àå Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå - ¼öÀͰú ¿¹Ãø(-2030³â) : À¯Çüº°
- ½ÃÀå¼öÀÍ Á¡À¯À²(2022³â, 2030³â)
- ŰƮ
- ±â±â
- ½Ã¾à
Á¦7Àå Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå - ¼öÀͰú ¿¹Ãø(-2030³â) : ¹æ¹ýº°
- ½ÃÀå¼öÀÍ Á¡À¯À²(2022³â, 2030³â)
- ÈÇÐÀû ¹æ¹ý
- ¹°¸®Àû ¹æ¹ý
Á¦8Àå Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå - ¼öÀͰú ¿¹Ãø(-2030³â) : »ùÇà À¯Çüº°
- ½ÃÀå¼öÀÍ Á¡À¯À²(2022³â, 2030³â)
- Ç÷¾×
- ü¾×
- ±âŸ
Á¦9Àå Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå - ¼öÀͰú ¿¹Ãø(-2030³â) : À¯·¡º°
- ½ÃÀå¼öÀÍ Á¡À¯À²(2022³â, 2030³â)
- °Ô³ð DNA
- ¹Ì»ý¹° DNA
Á¦10Àå Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå - ¼öÀͰú ¿¹Ãø(-2030³â) : ¿ëµµº°
- ½ÃÀå¼öÀÍ Á¡À¯À²(2022³â, 2030³â)
- PCR °Ë»ç
- Â÷¼¼´ë ½ÃÄö½Ì(NGS)
- ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
- ±âŸ
Á¦11Àå Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå - ¼öÀͰú ¿¹Ãø(-2030³â) : ÃÖÁ¾ »ç¿ëÀÚº°
- ½ÃÀå¼öÀÍ Á¡À¯À²(2022³â, 2030³â)
- º´¿ø, Áø´Ü¼¾ÅÍ, Á¶»ç ¿¬±¸¼Ò
- Á¦¾àȸ»ç, ¹ÙÀÌ¿ÀÁ¦¾àȸ»ç
- CRO
- ±âŸ
Á¦12Àå Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå - ¼öÀͰú ¿¹Ãø(-2030³â) : ±¹°¡º° ºÐ¼®
- Áß³²¹Ì
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ±âŸ Áß³²¹Ì
Á¦13Àå Áß³²¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå-¾÷°è Á¤¼¼
- À¯±âÀû ¼ºÀå Àü·«
- ¹«±âÀû ¼ºÀå Àü·«
Á¦14Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Bio-Rad Laboratories Inc
- Danaher Corp
- GE HealthCare Technologies Inc
- F. Hoffmann-La Roche Ltd
- Qiagen NV
- Merck KGaA
- Illumina Inc
- Takara Bio Inc
- Thermo Fisher Scientific Inc
Á¦15Àå ºÎ·Ï
BJH
The South & Central America DNA extraction, isolation, and purification market was valued at US$ 101.16 million in 2022 and is expected to reach US$ 193.64 million by 2030; it is estimated to grow at a CAGR of 8.5% from 2022 to 2030.
New Product Launches and Approvals Fuels the South & Central America DNA Extraction, Isolation, and Purification Market
The biotechnology industry is developing significantly due to the increasing demand for technologically advanced products. This, in turn, results in a rise in the number of new product developments, launches, and approvals. Additionally, major market players engage in R&D activities to ensure the innovation and development of efficient products. A few of the recent product launches and developments in the DNA extraction, isolation, and purification market are mentioned below.
CD Bioparticles is a leading manufacturer and supplier of various products in application areas such as in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. In August 2023, the company announced the launch of its new line of DNA extraction and purification kits made for the quick and accurate isolation of DNA, including cell-free DNA (cfDNA), genomic DNA, plasmid DNA, tissue DNA, mitochondrial DNA, and PCR In March 2023, BioEcho Life Sciences announced the launch of EchoLUTION FFPE DNA Kit that offers an innovative way to extract DNA from Formalin-Fixed Paraffin-Embedded (FFPE) samples. In April 2022, Purigen Biosystems, Inc., one of the leading providers of next-generation technologies, announced the launch of Ionic Cells to Pure DNA Kit. The kit has been optimized to allow the users of Ionic Purification Systems to extract higher-quality DNA from white blood cells (WBCs), peripheral blood mononuclear cells (PBMCs), and cultured or sorted cells.
Thus, an increase in product developments, and launches is likely to create ample opportunities for the growth of the DNA extraction, isolation, and purification market in the coming years.
South & Central America DNA Extraction, Isolation, and Purification Market Overview
The increasing prevalence of genetic diseases leads to clinical urgency for adopting rapid diagnostic options such as DNA kits, reagents, and instruments. In addition, the benefits of DNA products for rapid analysis and high-precision test results, and their use in a wide range of applications are among the major factors responsible for the increased adoption of DNA analysis in South & Central America. In Argentina, the growing demand for advanced diagnostic equipment in genetics, oncology, and cytogenetics has propelled the adoption of DNA products. According to the WHO, Argentina recorded ~130,878 new cancer cases in 2020. Rising cancer cases propel the demand for DNA extraction as this genetic material is instrumental in the early detection of genetic anomalies and in designing personalized treatment strategies. Thus, the increasing geriatric population, coupled with the burgeoning prevalence of cancer, highlights the importance of precise genetic analysis, which fuels the growth of the DNA extraction, isolation, and purification market in South & Central America.
South & Central America DNA Extraction, Isolation, and Purification Market Revenue and Forecast to 2030 (US$ Million)
South & Central America DNA Extraction, Isolation, and Purification Market Segmentation
The South & Central America DNA extraction, isolation, and purification market is segmented based on type, method, sample type, source, application, end user, and country.
Based on type, the South & Central America DNA extraction, isolation, and purification market is categorized into kits, instrument, and reagent. The kits segment held the largest South & Central America DNA extraction, isolation, and purification market share in 2022.
In terms of method, the South & Central America DNA extraction, isolation, and purification market is bifurcated into chemical method and physical method. The chemical method segment held a larger South & Central America DNA extraction, isolation, and purification market share in 2022. The chemical method is further subsegmented into phenol chloroform, silica gel, proteinase, and others. The physical method is further subsegmented into magnetic bead and paper.
By sample type, the South & Central America DNA extraction, isolation, and purification market is segmented into blood, body fluid, and others. The blood segment held the largest South & Central America DNA extraction, isolation, and purification market share in 2022.
By source, the South & Central America DNA extraction, isolation, and purification market is segmented into genomic and microbial. The genomic segment held a larger South & Central America DNA extraction, isolation, and purification market share in 2022. The microbial segment is further subsegmented into bacteria and virus.
Based on application, the South & Central America DNA extraction, isolation, and purification market is categorized into PCR test, next generation sequencing, micro array, and others. The next generation sequencing segment held the largest South & Central America DNA extraction, isolation, and purification market share in 2022. The PCR test segment is further subsegmented into qPCR, multiplex PCR, 16S PCR, and others.
By end user, the South & Central America DNA extraction, isolation, and purification market is segmented into diagnostic center and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The diagnostic center and research laboratories segment held the largest South & Central America DNA extraction, isolation, and purification market share in 2022.
Based on country, the South & Central America DNA extraction, isolation, and purification market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America DNA extraction, isolation, and purification market in 2022.
Bio-Rad Laboratories Inc, Danaher Corp, GE HealthCare Technologies Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Merck KGaA, Illumina Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America DNA extraction, isolation, and purification market.
Table Of Contents
Table of Content
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
- 2.2 South & Central America DNA Extraction, Isolation, and Purification Market, Market attractiveness
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. South & Central America DNA Extraction, Isolation, and Purification Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Emerging Applications of Extracted and Purified DNA
- 4.1.2 Rising R&D in Genomics
- 4.2 Market Restraints
- 4.2.1 High Cost of Process and Need for Highly Skilled Workforces
- 4.3 Market Opportunities
- 4.3.1 New Product Launches and Approvals
- 4.4 Future Trends
- 4.4.1 Technological Advancements Associated with Instruments
- 4.5 Impact Analysis
5. DNA Extraction, Isolation, and Purification Market - South & Central America Market Analysis
- 5.1 South & Central America DNA Extraction, Isolation, and Purification Market Revenue (US$ Mn), 2022 - 2030
6. South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by Type.
- 6.1 Overview
- 6.2 South & Central America DNA Extraction, Isolation, and Purification Market Revenue Share, by Type 2022 & 2030 (%)
- 6.3 Kits
- 6.3.1 Overview
- 6.3.2 Kits: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 6.4 Instrument
- 6.4.1 Overview
- 6.4.2 Instrument: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 6.5 Reagent
- 6.5.1 Overview
- 6.5.2 Reagent: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by Method.
- 7.1 Overview
- 7.2 South & Central America DNA Extraction, Isolation, and Purification Market Revenue Share, by Method 2022 & 2030 (%)
- 7.3 Chemical Methods
- 7.3.1 Overview
- 7.3.2 Chemical Methods: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.1 Phenol Chloroform Method
- 7.3.2.2 Phenol Chloroform Method: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.3 Silica Gel Method
- 7.3.2.3.1 Overview
- 7.3.2.3.2 Silica Gel Method: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.4 Proteinase K Method
- 7.3.2.4.1 Overview
- 7.3.2.4.2 Proteinase K Method: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.5 Others
- 7.3.2.5.1 Overview
- 7.3.2.5.2 Others: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Physical Methods
- 7.4.1 Overview
- 7.4.2 Physical Methods: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.2.1 Magnetic Bead Method
- 7.4.2.1.1 Overview
- 7.4.2.1.2 Magnetic Bead Method: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.2.2 Paper DNA Method
- 7.4.2.2.1 Overview
- 7.4.2.2.2 Paper DNA Method: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by Sample Type
- 8.1 Overview
- 8.2 South & Central America DNA Extraction, Isolation, and Purification Market Revenue Share, by Sample Type 2022 & 2030 (%)
- 8.3 Blood
- 8.3.1 Overview
- 8.3.2 Blood: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Body Fluids
- 8.4.1 Overview
- 8.4.2 Body Fluids: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by Source.
- 9.1 Overview
- 9.2 South & Central America DNA Extraction, Isolation, and Purification Market Revenue Share, by Source 2022 & 2030 (%)
- 9.3 Genomic DNA
- 9.3.1 Overview
- 9.3.2 Genomic DNA: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Microbial DNA
- 9.4.1 Overview
- 9.4.2 Microbial DNA: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4.2.1 Bacterial
- 9.4.2.1.1 Overview
- 9.4.2.1.2 Bacterial: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4.2.2 Virus
- 9.4.2.2.1 Overview
- 9.4.2.2.2 Virus: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by Application.
- 10.1 Overview
- 10.2 South & Central America DNA Extraction, Isolation, and Purification Market Revenue Share, by Application 2022 & 2030 (%)
- 10.3 PCR Test
- 10.3.1 Overview
- 10.3.2 PCR Test: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3.2.1 qPCR
- 10.3.2.1.1 Overview
- 10.3.2.1.2 qPCR: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3.2.2 Multiplex PCR
- 10.3.2.2.1 Overview
- 10.3.2.2.2 Multiplex PCR: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3.2.3S PCR
- 10.3.2.3.1 Overview
- 10.3.2.3.2S PCR: DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3.2.4 Others
- 10.3.2.4.1 Overview
- 10.3.2.4.2 Others: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4 Next Generation Sequencing (NGS)
- 10.4.1 Overview
- 10.4.2 Next Generation Sequencing (NGS): South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.5 Microarray
- 10.5.1 Overview
- 10.5.2 Microarray: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
11. South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by End User
- 11.1 Overview
- 11.2 South & Central America DNA Extraction, Isolation, and Purification Market Revenue Share, by End User 2022 & 2030 (%)
- 11.3 Hospitals, Diagnostic Center, and Research Laboratories
- 11.3.1 Overview
- 11.3.2 Hospitals Diagnostic Center and Research Laboratories: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4 Pharmaceutical and Biopharmaceutical Companies
- 11.4.1 Overview
- 11.4.2 Pharmaceutical and Biopharmaceutical Companies: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5 CROs
- 11.5.1 Overview
- 11.5.2 CROs: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 11.6 Others
- 11.6.1 Overview
- 11.6.2 Others: South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
12. South & Central America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - Country Analysis
- 12.1 South & Central America: DNA Extraction, Isolation, and Purification Market
- 12.1.1 South & Central America: DNA Extraction, Isolation, and Purification Market Share by Country - 2022 & 2030, (%)
- 12.1.1.1 Brazil: DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 12.1.1.1.1 Brazil: DNA Extraction, Isolation, and Purification Market, by Type, 2020-2030 (US$ Million)
- 12.1.1.1.2 Brazil: DNA Extraction, Isolation, and Purification Market, by Method, 2020-2030 (US$ Million)
- 12.1.1.1.2.1 Brazil: DNA Extraction, Isolation, and Purification Market, For Chemical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.1.2.2 Brazil: DNA Extraction, Isolation, and Purification Market, For Physical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.1.3 Brazil: DNA Extraction, Isolation, and Purification Market, by Sample Type, 2020-2030 (US$ Million)
- 12.1.1.1.4 Brazil: DNA Extraction, Isolation, and Purification Market, by Source, 2020-2030 (US$ Million)
- 12.1.1.1.4.1 Brazil: DNA Extraction, Isolation, and Purification Market, For Microbial DNA by Source, 2020-2030 (US$ Million)
- 12.1.1.1.5 Brazil: DNA Extraction, Isolation, and Purification Market, by Application, 2020-2030 (US$ Million)
- 12.1.1.1.5.1 Brazil: DNA Extraction, Isolation, and Purification Market, by For PCR Test by Application, 2020-2030 (US$ Million)
- 12.1.1.1.6 Brazil: DNA Extraction, Isolation, and Purification Market, by End User, 2020-2030 (US$ Million)
- 12.1.1.2 Argentina: DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 12.1.1.2.1 Argentina: DNA Extraction, Isolation, and Purification Market, by Type, 2020-2030 (US$ Million)
- 12.1.1.2.2 Argentina: DNA Extraction, Isolation, and Purification Market, by Method, 2020-2030 (US$ Million)
- 12.1.1.2.2.1 Argentina: DNA Extraction, Isolation, and Purification Market, For Chemical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.2.2.2 Argentina: DNA Extraction, Isolation, and Purification Market, For Physical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.2.3 Argentina: DNA Extraction, Isolation, and Purification Market, by Sample Type, 2020-2030 (US$ Million)
- 12.1.1.2.4 Argentina: DNA Extraction, Isolation, and Purification Market, by Source, 2020-2030 (US$ Million)
- 12.1.1.2.4.1 Argentina: DNA Extraction, Isolation, and Purification Market, For Microbial DNA by Source, 2020-2030 (US$ Million)
- 12.1.1.2.5 Argentina: DNA Extraction, Isolation, and Purification Market, by Application, 2020-2030 (US$ Million)
- 12.1.1.2.5.1 Argentina: DNA Extraction, Isolation, and Purification Market, by For PCR Test by Application, 2020-2030 (US$ Million)
- 12.1.1.2.6 Argentina: DNA Extraction, Isolation, and Purification Market, by End User, 2020-2030 (US$ Million)
- 12.1.1.3 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 12.1.1.3.1 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market, by Type, 2020-2030 (US$ Million)
- 12.1.1.3.2 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market, by Method, 2020-2030 (US$ Million)
- 12.1.1.3.2.1 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market, For Chemical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.3.2.2 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market, For Physical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.3.3 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market, by Sample Type, 2020-2030 (US$ Million)
- 12.1.1.3.4 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market, by Source, 2020-2030 (US$ Million)
- 12.1.1.3.4.1 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market, For Microbial DNA by Source, 2020-2030 (US$ Million)
- 12.1.1.3.5 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market, by Application, 2020-2030 (US$ Million)
- 12.1.1.3.5.1 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market, by For PCR Test by Application, 2020-2030 (US$ Million)
- 12.1.1.3.6 Rest of South & Central America: DNA Extraction, Isolation, and Purification Market, by End User, 2020-2030 (US$ Million)
13. South & Central America DNA Extraction, Isolation, and Purification Market-Industry Landscape
- 13.1 Overview
- 13.2 Organic Growth Strategies
- 13.3 Inorganic Growth Strategies
14. Company Profiles
- 14.1 Bio-Rad Laboratories Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 Danaher Corp
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 GE HealthCare Technologies Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 F. Hoffmann-La Roche Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Qiagen NV
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Illumina Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
- 14.8 Takara Bio Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Thermo Fisher Scientific Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
- 15.1 About Us
- 15.2 Glossary of Terms